Fact CheckerSign in

NCT04663217Completed

Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension

Source: ClinicalTrials.gov · Last updated 17 May 2024

Brief summary (registry, in English)

This study aims to investigate the exercise profile in pulmonary hypertension patients with either pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension or pulmonary hypertension due to left heart disease and in disease control.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
5 Nov 2020
Start date
1 Nov 2020
Primary completion date
4 Nov 2022
Lead sponsor
University of Giessen
NCT number
NCT04663217

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 1 Nov 2020 to the primary completion date, 4 Nov 2022
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other etiologic groups of pulmonary hypertension (World Health Organization group 3, 5)
  • Unstable or severe coronary artery disease
  • Uncontrolled arterial hypertension
  • Severe congenital or acquired valvular or myocardial disease
  • Progressive left heart failure
  • History of severe ventricular arrhythmias
  • Severe, terminal renal impairment
  • Severe obstructive or restrictive lung disease
  • Severe lung emphysema or interstitial lung disease

Lab values

  • Left ventricular ejection fraction \< 30%

Who the study is looking for

  • Confirmed diagnosis of pulmonary arterial hypertension (World Health Organization group 1)
  • Pulmonary hypertension due to left heart disease (World Health Organization group 2)
  • Chronic thromboembolic pulmonary hypertension (World Health Organization group 4)
  • Invasive exclusion of pulmonary hypertension
  • Age ≥ 18 years
  • Planned right heart catheterization based on clinical grounds
  • Stable specific PAH medications
  • Ability to undergo cycle ergometry
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kerckhoff-Klinik
Coordinator of this site? Confirm its status
Bad NauheimGermanyUnknown status
University of Giessen
Coordinator of this site? Confirm its status
GiessenGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.